Robert Desantis Sells 1,498 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 1,498 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the transaction, the executive vice president now directly owns 5,507 shares in the company, valued at $2,037,149.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Robert Desantis also recently made the following trade(s):

• On Monday, April 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.39, for a total transaction of $141,146.64.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.16, for a total transaction of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $371.70 on Thursday. The stock has a market capitalization of $131.84 billion, a price-to-earnings ratio of 67.09, a price-to-earnings-growth ratio of 4.83 and a beta of 1.36. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76. The company’s fifty day moving average is $385.79 and its two-hundred day moving average is $348.35.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 earnings per share. Sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on ISRG. Citigroup lifted their price objective on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Barclays lifted their price objective on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Raymond James lifted their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Truist Financial upped their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Finally, StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $396.17.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently modified their holdings of ISRG. Norges Bank bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $1,313,238,000. WCM Investment Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $575,536,000. International Assets Investment Management LLC grew its position in Intuitive Surgical by 32,360.5% in the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock valued at $231,721,000 after buying an additional 684,749 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Intuitive Surgical by 111.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after buying an additional 678,375 shares in the last quarter. Finally, Alphinity Investment Management Pty Ltd grew its position in Intuitive Surgical by 113.2% in the 4th quarter. Alphinity Investment Management Pty Ltd now owns 1,276,158 shares of the medical equipment provider’s stock valued at $430,525,000 after buying an additional 677,455 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.